https://peter-blog.pages.dev/tags/%E4%BB%BF%E8%A3%BD%E8%97%A5/Recent content in 仿製藥 on Peter's BlogHugozh-twThu, 09 Apr 2026 00:00:00 +0000https://peter-blog.pages.dev/india/asia-generic-ozempic-weight-loss-abuse-risk/Thu, 09 Apr 2026 00:00:00 +0000https://peter-blog.pages.dev/india/asia-generic-ozempic-weight-loss-abuse-risk/印度與中國仿製藥廠在 semaglutide 專利到期後推出廉價版本，雖讓糖尿病患者受惠，但也引發减肥藥濫用擔憂。